Beyens A, Albuisson J, Boel A, Al-Essa M, Al-Manea W, Bonnet D, Bostan O, Boute O, Busa T, Canham N, Cil E, Coucke PJ, Cousin MA, Dasouki M, De Backer J, De Paepe A, De Schepper S, De Silva D, Devriendt K, De Wandele I, Deyle DR, Dietz H, Dupuis-Girod S, Fontenot E, Fischer-Zirnsak B, Gezdirici A, Ghoumid J, Giuliano F, Diz NB, Haider MZ, Hardin JS, Jeunemaitre X, Klee EW, Kornak U, Landecho MF, Legrand A, Loeys B, Lyonnet S, Michael H, Moceri P, Mohammed S, Muio-Mosquera L, Nampoothiri S, Pichler K, Prescott K, Rajeb A, Ramos-Arroyo M, Rossi M, Salih M, Seidahmed MZ, Schaefer E, Steichen-Gersdorf E, Temel S, Uysal F, Vanhomwegen M, Van Laer L, Van Maldergem L, Warner D, Willaert A, Collins TR, Taylor A, Davis EC, Zarate Y, Callewaert B
Expression of tight junction and drug efflux transporter proteins in an in vitro model of human blood-brain barrier
At Intra-V, your provider reviews: health history and goals medications and risk factors and, when appropriate, lab work to guide your protocol Important note: Peptide therapy is personalized
RUO All Products 25.99 51.90 54.99 69.99 44.90 64.99 139.90 189.90 39.90 4.89 13.90 49.90 48.90 57.90 Out of Stock 104.90 8.90 42.90 39.99 69.90 59.90 44.90 79.90 22.90 169.90 5.90 9.99 14.90 7.90 48.90
Funding Open access funding provided by the National Institutes of Health
Combine with a Holistic Approach Peptides should be integrated into a comprehensive arthritis management plan that includes lifestyle changes, such as a balanced diet, regular exercise, and stress management